These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20136491)

  • 21. Solubility of ocular therapeutic agents in self-emulsifying oils. I. Self-emulsifying oils for ocular drug delivery: solubility of indomethacin, aciclovir and hydrocortisone.
    Czajkowska-Kośnik A; Sznitowska M
    Acta Pol Pharm; 2009; 66(6):709-13. PubMed ID: 20050536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs.
    Wang F; Hui H; Barnes TJ; Barnett C; Prestidge CA
    Mol Pharm; 2010 Feb; 7(1):227-36. PubMed ID: 19874003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
    Gursoy RN; Benita S
    Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mode of administration-dependent brain uptake of indomethacin: sustained systemic input increases brain influx.
    Dahan A; Hoffman A
    Drug Metab Dispos; 2007 Feb; 35(2):321-4. PubMed ID: 17142563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic evaluation of indomethacin nanocapsules.
    Andrieu V; Fessi H; Dubrasquet M; Devissaguet JP; Puisieux F; Benita S
    Drug Des Deliv; 1989 Jun; 4(4):295-302. PubMed ID: 2775449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of various vehicles on diclofenac sodium and indomethacin pharmaceutical availability.
    Stozkowska W
    Acta Pol Pharm; 2002; 59(4):253-8. PubMed ID: 12403299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
    Sonaje K; Lin KJ; Wey SP; Lin CK; Yeh TH; Nguyen HN; Hsu CW; Yen TC; Juang JH; Sung HW
    Biomaterials; 2010 Sep; 31(26):6849-58. PubMed ID: 20619787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies.
    Zhao Y; Wang C; Chow AH; Ren K; Gong T; Zhang Z; Zheng Y
    Int J Pharm; 2010 Jan; 383(1-2):170-7. PubMed ID: 19732813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and performance evaluation of saquinavir laden cationic submicron emulsions.
    Jain V; Prasad V; Jadhav P; Mishra PR
    Drug Deliv; 2009 Jan; 16(1):37-44. PubMed ID: 19555307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs.
    Cattani VB; Fiel LA; Jäger A; Jäger E; Colomé LM; Uchoa F; Stefani V; Dalla Costa T; Guterres SS; Pohlmann AR
    Eur J Pharm Sci; 2010 Jan; 39(1-3):116-24. PubMed ID: 19932749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phytopreventative effects of Gynostemma pentaphyllum against acute Indomethacin-induced gastrointestinal and renal toxicity in rats.
    Hesse C; Razmovski-Naumovski V; Duke CC; Davies NM; Roufogalis BD
    Phytother Res; 2007 Jun; 21(6):523-30. PubMed ID: 17380554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
    Chandrashekar NS; Shobha Rani RH
    J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transnasal delivery of 5-fluorouracil to the brain in the rat.
    Sakane T; Yamashita S; Yata N; Sezaki H
    J Drug Target; 1999; 7(3):233-40. PubMed ID: 10680979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic desorption of layer-by-layer assembled multilayer films and effects on the release of encapsulated indomethacin microcrystals.
    Wang C; Ye S; Dai L; Liu X; Tong Z
    Carbohydr Res; 2007 Nov; 342(15):2237-43. PubMed ID: 17662265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon.
    Zambito Y; Baggiani A; Carelli V; Serafini MF; Di Colo G
    J Control Release; 2005 Feb; 102(3):669-77. PubMed ID: 15681088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil.
    Simeonova M; Velichkova R; Ivanova G; Enchev V; Abrahams I
    Int J Pharm; 2003 Sep; 263(1-2):133-40. PubMed ID: 12954188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of food on the pharmacokinetics of S-1 after single oral administration to patients with solid tumors.
    Peters GJ; Noordhuis P; Van Groeningen CJ; Giaccone G; Holwerda U; Voorn D; Schrijvers A; Schornagel JH; Beijnen JH; Fumoleau P; Schellens JH
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4072-6. PubMed ID: 15217941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.
    Rao SV; Yajurvedi K; Shao J
    Int J Pharm; 2008 Oct; 362(1-2):16-9. PubMed ID: 18650037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type and distribution of indomethacin-induced lesions in the gastrointestinal tract of rat.
    Kunes M; Kvetina J; Bures J
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():96-100. PubMed ID: 20027152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.
    Shirasaka T; Shimamoto Y; Fukushima M
    Cancer Res; 1993 Sep; 53(17):4004-9. PubMed ID: 7689420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.